Lipocine Inc. Files 8-K Report
Ticker: LPCN · Form: 8-K · Filed: Apr 11, 2024 · CIK: 1535955
| Field | Detail |
|---|---|
| Company | Lipocine Inc. (LPCN) |
| Form Type | 8-K |
| Filed Date | Apr 11, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.0001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, SEC Filing, Financials
Related Tickers: LPCN
TL;DR
LPCN filed an 8-K, likely with financial updates. Watch for details.
AI Summary
On April 11, 2024, Lipocine Inc. filed an 8-K report. The filing primarily concerns "Other Events" and "Financial Statements and Exhibits," indicating updates or disclosures related to the company's financial status and significant occurrences. No specific new financial figures or events were detailed in the provided excerpt.
Why It Matters
This filing signals that Lipocine Inc. is providing updates to the SEC, which could contain material information for investors regarding the company's operations or financial health.
Risk Assessment
Risk Level: low — The filing is a standard procedural report and does not, in itself, indicate any immediate financial distress or significant negative events.
Key Players & Entities
- Lipocine Inc. (company) — Registrant
- 001-36357 (company) — Commission File Number
- April 11, 2024 (date) — Date of Report
- 675 Arapeen Drive, Suite 202 (location) — Principal Executive Offices Address
- Salt Lake City, Utah 84108 (location) — Principal Executive Offices City, State, Zip
FAQ
What specific "Other Events" are being reported by Lipocine Inc. in this 8-K filing?
The provided excerpt does not detail the specific "Other Events" being reported, only that this item is included in the filing.
What financial statements or exhibits are included in this 8-K filing?
The excerpt indicates that "Financial Statements and Exhibits" are part of the filing, but does not list their specific contents.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing was on April 11, 2024.
What is Lipocine Inc.'s principal executive office address?
Lipocine Inc.'s principal executive office is located at 675 Arapeen Drive, Suite 202, Salt Lake City, Utah 84108.
What is Lipocine Inc.'s telephone number?
Lipocine Inc.'s telephone number, including area code, is (801) 994-7383.
Filing Stats: 493 words · 2 min read · ~2 pages · Grade level 12 · Accepted 2024-04-11 07:24:28
Key Financial Figures
- $0.0001 — ch registered Common Stock, par value $0.0001 per share LPCN The NASDAQ Stock Mar
Filing Documents
- form8-k.htm (8-K) — 41KB
- form8-k_001.jpg (GRAPHIC) — 9KB
- ex99-1.htm (EX-99.1) — 49KB
- ex99-2.htm (EX-99.1) — 11KB
- ex99-2_001.jpg (GRAPHIC) — 174KB
- ex99-2_002.jpg (GRAPHIC) — 1016KB
- ex99-2_003.jpg (GRAPHIC) — 254KB
- ex99-2_004.jpg (GRAPHIC) — 272KB
- ex99-2_005.jpg (GRAPHIC) — 238KB
- ex99-2_006.jpg (GRAPHIC) — 251KB
- ex99-2_007.jpg (GRAPHIC) — 173KB
- ex99-2_008.jpg (GRAPHIC) — 166KB
- ex99-2_009.jpg (GRAPHIC) — 244KB
- ex99-2_010.jpg (GRAPHIC) — 209KB
- ex99-2_011.jpg (GRAPHIC) — 203KB
- ex99-2_012.jpg (GRAPHIC) — 175KB
- ex99-2_013.jpg (GRAPHIC) — 211KB
- ex99-2_014.jpg (GRAPHIC) — 188KB
- ex99-2_015.jpg (GRAPHIC) — 235KB
- ex99-2_016.jpg (GRAPHIC) — 228KB
- ex99-2_017.jpg (GRAPHIC) — 224KB
- ex99-2_018.jpg (GRAPHIC) — 219KB
- ex99-1_001.jpg (GRAPHIC) — 4KB
- 0001493152-24-014273.txt ( ) — 6753KB
- lpcn-20240411.xsd (EX-101.SCH) — 3KB
- lpcn-20240411_lab.xml (EX-101.LAB) — 33KB
- lpcn-20240411_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. LIPOCINE INC. Date: April 11, 2024 By: /s/ Mahesh V. Patel Mahesh V. Patel President and Chief Executive Officer